-A A +A
March 30, 2017

Controversial changes to drug patent and copyright rules required under Canada’s recent trade deals will have manageable side effects, according to a new report from the C.D. Howe Institute. In “Patents, Copyright and Competition: Assessing the Impact of Trade Deals on Canada,” authors Daniel Schwanen and Aaron Jacobs review claims that strengthened protection for patents and copyright would result in a dramatic  increase in healthcare costs as well as  copyright payments, and provide some estimates of their own. 

Daniel Schwanen

Daniel Schwanen is the Vice President of Research and leads the C.D. Howe Institute's trade and international policy program.  He is an award-winning economist with a passion for international economic policy. He is spearheading Institute programs focused on the link between Canada’s international trade and investment policy and Canadians’ standards of living.